000			01780 a2200505 4500
005			20250515044004.0
264		0	_c20070322
008			200703s 0 0 eng d
022			_a0929-1903
024	7		_a10.1038/sj.cgt.7701007 _2doi
040			_aNLM _beng _cNLM
100	1		_aDzojic, H
245	0	0	_aTwo-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model. _h[electronic resource]
260			_bCancer gene therapy _cMar 2007
300			_a233-40 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xgenetics
650	0	4	_aAdenoviridae _xgenetics
650	0	4	_aAnimals
650	0	4	_aAntigens, Surface _xgenetics
650	0	4	_aDisease Models, Animal
650	0	4	_aEnhancer Elements, Genetic
650	0	4	_aGene Amplification
650	0	4	_aGene Expression Regulation, Neoplastic _xphysiology
650	0	4	_aGenetic Therapy
650	0	4	_aGlutamate Carboxypeptidase II _xgenetics
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Nude
650	0	4	_aNuclear Proteins _xgenetics
650	0	4	_aPromoter Regions, Genetic _xgenetics
650	0	4	_aProstate-Specific Antigen _xgenetics
650	0	4	_aProstatic Neoplasms _xgenetics
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aTrans-Activators _xgenetics
650	0	4	_aTransfection
650	0	4	_aTumor Cells, Cultured
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aCheng, W-S
700	1		_aEssand, M
773	0		_tCancer gene therapy _gvol. 14 _gno. 3 _gp. 233-40
856	4	0	_uhttps://doi.org/10.1038/sj.cgt.7701007 _zAvailable from publisher's website
999			_c16629078 _d16629078